Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/21092
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVenetsanou, K.en
dc.contributor.authorVlachos, K.en
dc.contributor.authorMoles, A.en
dc.contributor.authorFragakis, G.en
dc.contributor.authorFildissis, G.en
dc.contributor.authorBaltopoulos, G.en
dc.date.accessioned2015-11-24T19:12:37Z-
dc.date.available2015-11-24T19:12:37Z-
dc.identifier.issn1148-5493-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/21092-
dc.rightsDefault Licence-
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAgeden
dc.subjectBrain Injuries/*blood/*therapyen
dc.subjectCytokines/*biosynthesis/metabolismen
dc.subjectEnzyme-Linked Immunosorbent Assay/methodsen
dc.subjectFemaleen
dc.subjectGlasgow Coma Scaleen
dc.subjectHumansen
dc.subjectHypolipoproteinemias/*blooden
dc.subjectInflammationen
dc.subjectInterleukin-6/metabolismen
dc.subjectInterleukin-8/metabolismen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.titleHypolipoproteinemia and hyperinflammatory cytokines in serum of severe and moderate traumatic brain injury (TBI) patientsen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1684/ecn.2007.0112-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17993453-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2007-
heal.abstractTraumatic brain injury (TBI) acts as an inducer of the inflammatory reaction expressed by the release of pro-inflammatory cytokines (interleukin-1beta [IL-1beta], interleukin-6 [IL-6] and interleukin-8 [IL-8]), and causes metabolic alterations in the early, post-traumatic state, either in the brain or/and the systemic circulation. The metabolic changes involve carbohydrates, proteins and lipids. We focused on the serum lipid profile, the impact of trauma on lipoproteins, and their subsequent effects, on inflammation. We investigated the role of cytokines and serum lipids, in patient outcome, reviewing 30-day mortality and the Glasgow Coma Scale (GCS). A total of 75 patients with severe or moderate TBI (GCS <or= 13) were allocated to two groups (group 1 non-survivors and group 2 survivors). One blood sample was collected from each patient within 24h of admission. Cytokines were measured in serum by ELISA and serum lipids using an enzymatic method. We found significantly decreased serum lipid levels and increased cytokines levels for all patients compared with healthy volunteers. Comparing the two groups, IL-6 and IL-8 levels were higher (p<0.0001) and LDL levels lower (p=0.003) in non-survivors than in survivors. We observed a significant inverse correlation between IL-8 and LDL (p=0.04) in patients with an unfavorable outcome. Our results suggest that LDL alone, or in combination with IL-6 and IL-8, could be a possible prognostic factor for outcome in patients with TBI, as regards 30- day mortality.en
heal.journalNameEur Cytokine Netwen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons